Influence of Deviation From Guidelines on the Outcome of Community-Acquired Pneumonia

Woodhead, 1987, Prospective study of the aetiology and outcome of pneumonia in the community, Lancet, 1, 671, 10.1016/S0140-6736(87)90430-2 Marston, 1997, Incidence of community acquired pneumonia requiring hospitalization: results of a population based active surveillance study in Ohio, Arch Intern Med, 157, 1709, 10.1001/archinte.1997.00440360129015 Sobradillo, 1993, Etiología de la neumonía de la comunidad en España, Arch Bronconeumol, 29, 365, 10.1016/S0300-2896(15)31162-5 Fine, 1995, Prognosis and outcomes of patients with community-acquired pneumonia: a meta-analysis, JAMA, 274, 134 Pachon, 1990, Severe community-acquired pneumonia: etiology, prognosis and treatment, Am Rev Respir Dis, 142, 369, 10.1164/ajrccm/142.2.369 Torres, 1991, Severe community-acquired pneumonia: epidemiology and prognostic factors, Am Rev Respir Dis, 144, 312, 10.1164/ajrccm/144.2.312 Moine, 1994, Severe community-acquired pneumonia: etiology, epidemiology and prognostic factors, Chest, 105, 1487, 10.1378/chest.105.5.1487 Huchon, 1998, Guidelines for management of adult community-acquired lower respiratory tract infectious, Eur Respir J, 11, 986, 10.1183/09031936.98.11040986 Niederman, 1993, Guidelines for the initial management of adults with community-acquired pneumonia: diagnosis, assessment of severity, and initial antimicrobial therapy, Am Rev Respir Dis, 148, 1418, 10.1164/ajrccm/148.5.1418 Ruiz, 1999, Etiology of community-acquired pneumonia: impact of age, comorbidity, and severity, Am J Respir Crit Care Med, 160, 397, 10.1164/ajrccm.160.2.9808045 Dorca, 1997, Diagnóstico y tratamiento de la neumonía adquirida en la comunidad, Arch Bronconeumol, 33, 240, 10.1016/S0300-2896(15)30614-1 Woolf, 1998, Do clinical practice guidelines define good medical care? The need for good science and the disclosure of uncertainty when defining “best practices.”, Chest, 113, 166S, 10.1378/chest.113.3_Supplement.166S Heffner, 1998, Does evidence-based medicine help the development of clinical practice guidelines?, Chest, 113, 172S, 10.1378/chest.113.3_Supplement.172S Niederman, 1996, Guidelines for the management of respiratory infection: why do we need them, how should they be developed, and can they be useful?, Curr Opin Pulm Med, 2, 161, 10.1097/00063198-199605000-00001 Fine, 1997, A prediction rule to identify low-risk patients with community acquired pneumonia, N Engl J Med, 336, 243, 10.1056/NEJM199701233360402 Fein, 1995, Guidelines for the initial management of community-acquired pneumonia: savory recipe or cookbook for disaster?, Am J Respir Crit Care Med, 152, 1149, 10.1164/ajrccm.152.4.7551362 Gleason, 1997, Medical outcomes and antimicrobial costs with the use of the American Thoracic Society guidelines for outpatients with community-acquired pneumonia, JAMA, 278, 32, 10.1001/jama.1997.03550010046038 Hirani, 1997, Impact of management guidelines on the outcome of severe community acquired pneumonia, Thorax, 52, 17, 10.1136/thx.52.1.17 Bartlett, 2000, Practice guidelines for the management of community-acquired pneumonia in adults, Clin Infect Dis, 31, 347, 10.1086/313954 1998, ERS task force report: guidelines for management of adult community-acquired lower respiratory tract infections, Eur Respir J, 11, 986, 10.1183/09031936.98.11040986 Heffelfinger, 2000, Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group, Arch Intern Med, 160, 1399, 10.1001/archinte.160.10.1399 Bernstein, 1999, Treatment of community-acquired pneumonia: IDSA guidelines, Chest, 115, 9S, 10.1378/chest.115.suppl_1.9S Marrie, 1999, Risks and outcomes in community acquired pneumonia, Can Respir J, 6, 6A Marie, 1998, Community-acquired pneumonia: epidemiology, etiology, treatment, Infect Dis Clin North Am, 12, 723, 10.1016/S0891-5520(05)70207-5 Fein, 1999, Pneumonia in the elderly: overview of diagnostic and therapeutic approaches, Clin Infect Dis, 28, 726, 10.1086/515218 Bartlett, 2000, Treatment of community-acquired pneumonia, Chemotherapy, 46, 24, 10.1159/000048489 Frias, 1998, Tratamiento antibiotico empírico inicial de la neumonía adguirida en la comunidad, Rev Esp Quimioter, 11, 255 Blanquer, 1991, Aetiology of community-acquired pneumonia in Valencia, Spain: a multicentre prospective study, Thorax, 46, 508, 10.1136/thx.46.7.508 Almirall, 1993, Incidence of community-acquired pneumonia and Chlamydia pneumoniae infection: a prospective multicentre study, Eur Respir J, 6, 14, 10.1183/09031936.93.06010014 Marras, 1998, Use of guidelines in treating community-acquired pneumonia, Chest, 113, 1689, 10.1378/chest.113.6.1689 Schwartz, 1998, Preventing mismanagement of community-acquired pneumonia at an urban public hospital: implications for institution-specific practice guidelines, Chest, 113, 194S, 10.1378/chest.113.3_Supplement.194S Menéndez, 1999, Value of the polymerase chain reaction assay in noninvasive respiratory samples for diagnosis of community-acquired pneumonia, Am J Respir Crit Care Med, 159, 1868, 10.1164/ajrccm.159.6.9807070 Gleason, 1999, Associatons between initial antimicrobial therapy and medical outcomes for hospitalized elderly patients with pneumonia, Arch Intern Med, 159, 2562, 10.1001/archinte.159.21.2562 Dudas, 2000, Antimicrobial selection for hospitalized patients with presumed community-acquired pneumonia: a survey of nonteaching US community hospitals, Ann Pharmacother, 34, 446, 10.1345/aph.19174 Stahl, 1999, Effect of macrolides as part of initial empiric therapy on length of stay in patients hospitalized with community-acquired pneumonia, Arch Intern Med, 159, 2576, 10.1001/archinte.159.21.2576 Dowell, 1999, The best treatment for pneumonia: new clues, but no definitive answers, Arch Intern Med, 159, 2511, 10.1001/archinte.159.21.2511 Weingarten, 1998, Can practice guidelines safely reduced hospital length of stay? Results from a multicenter interventional study, Am J Med, 105, 33, 10.1016/S0002-9343(98)00129-6 Fine, 1993, Differences in length of hospital stay in patients with community-acquired pneumonia: a prospective four-hospital study, Med Care, 31, 371, 10.1097/00005650-199304000-00008 Fine, 1997, The hospital discharge decision for patients with community-acquired pneumonia: results from the Pneumonia Patient Outcomes Research Team Cohort Study, Arch Intern Med, 157, 47, 10.1001/archinte.1997.00440220051007 McCormick, 1999, Variation in length of hospital stay in patients with community-acquired pneumonia: are shorter stays associated with worse medical outcomes?, Am J Med, 107, 5, 10.1016/S0002-9343(99)00158-8 Feagan, 2000, Treatment and outcomes of community-acquired pneumonia at Canadian hospitals, Can Med Assoc J, 162, 1415 Menéndez, 2001, Initial risk class and length of stay in community-acquired pneumonia, Eur Respir J, 18, 151, 10.1183/09031936.01.00090001 Marrie, 2000, A controlled trial of a critical pathway for treatment of community-acquired pneumonia, JAMA, 283, 749, 10.1001/jama.283.6.749 Ailani, 1999, Doxycycline is a cost-effective therapy for hospitalized patients with community-acquired pneumonia, Arch Intern Med, 159, 1814, 10.1001/archinte.159.3.266